atorvastatin calcium · Upjohn · NDA 020702
Lipitor
Earliest generic entry, as listed · earliest of 4 marketed strengths
Open now
No unexpired patents or exclusivities are listed for this product.
Listed patents · 0 unexpired
No unexpired patents listed.
Exclusivities · 0 unexpired
No unexpired exclusivities listed.
Paragraph IV certifications · 0
No Paragraph IV certification listed by FDA for this drug.
The list shows that a generic applicant certified to FDA that a listed patent is invalid or not infringed. It does not show litigation, settlements or launch timing.
Event history
- Generic approved · ANDA 220276, Teva Pharms Inc · 020702-001Approved 13 Nov 2025Detected 25 Oct 2026Historical import
Products covered · 4
| NDA · product | Form | Strength | Listed expiry |
|---|---|---|---|
| 020702 · 001 · RLD | tablet, oral | EQ 10MG BASE | open |
| 020702 · 002 · RLD | tablet, oral | EQ 20MG BASE | open |
| 020702 · 003 · RLD | tablet, oral | EQ 40MG BASE | open |
| 020702 · 004 · RLD | tablet, oral | EQ 80MG BASE | open |